Sign In
Buy FOLD
$14.49
+0 (+0%)
At Close: Jun 03, 2026
Amicus Therapeutics to Present at the Evercore ISI 3rd Annual HealthCONx Conference
07:00am, Monday, 23'rd Nov 2020
CRANBURY, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the Everco
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q3 2020 Results - Earnings Call Transcript
02:26pm, Thursday, 05'th Nov 2020
Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q3 2020 Results - Earnings Call Transcript
Amicus Therapeutics (FOLD) Reports Q3 Loss, Tops Revenue Estimates
09:15am, Thursday, 05'th Nov 2020
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -10.00% and 3.69%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock
Amicus Therapeutics to Present at the Credit Suisse 29th Annual Virtual Healthcare Conference
07:00am, Monday, 02'nd Nov 2020
CRANBURY, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and Chief Executive Officer, will present at the Credit Suisse 29th
Software provider in vaccine clinical trials hit with ransomware attack
03:00am, Friday, 09'th Oct 2020
ERT, a medical technology company that sells software used in clinical trials, was hit with a ransomware attack in September, raising concerns about attacks on COVID-19 vaccine development efforts.
US: Clinical trials hit by ransomware attack on health tech firm
03:01pm, Sunday, 04'th Oct 2020
The attack on eResearchTechnology Inc., which has not previously been reported, began two weeks ago when employees discovered that they were locked out of their data by ransomware, an attack that hold
COVID vaccine and trials at risk as Philadelphia firm hit by cyberhack
10:32pm, Saturday, 03'rd Oct 2020
A Philadelphia-based company has been battling a ransomware attack that begun on September 20, it has emerged, threatening the software used in COVID vaccine research and trials.
Amicus Therapeutics (FOLD) Investor Presentation - Slideshow
03:44pm, Friday, 11'th Sep 2020
The following slide deck was published by Amicus Therapeutics, Inc. in conjunction with this event..
Amicus Therapeutics Inc (FOLD) Q2 2020 Earnings Call Transcript
11:01pm, Monday, 10'th Aug 2020
Thank you for joining our conference call to discuss Amicus Therapeutics' second quarter 2020 financial results and corporate highlights. Speaking on today's call, we have John Crowley, Chairman and
Amicus Therapeutics (FOLD) Reports Q2 Loss, Misses Revenue Estimates
12:25pm, Monday, 10'th Aug 2020
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 23.08% and -0.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Amicus Therapeutics Q2 Earnings
11:27am, Monday, 10'th Aug 2020
Shares of Amicus Therapeutics (NASDAQ:FOLD) rose 0.6% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 44.44% year over year to ($0.20), which
Amicus Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates
11:00am, Monday, 10'th Aug 2020
Galafold 2Q2020 Revenue of $62.4 Million, On-Track to Achieve 2020 Revenue Guidance of $250M-$260MAT-GAA Phase 3 PROPEL Study Readout and Rolling BLA Submission to U.S. FDA on ScheduleAdvancing In
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Outlook on the Worldwide Hunter Syndrome Industry to 2030 - ResearchAndMarkets.com
12:00am, Friday, 07'th Aug 2020
The
Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference
11:00am, Tuesday, 04'th Aug 2020
CRANBURY, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that members of the Amicus senior leadership team will participate in a fireside chat at the BTIG V
